Solubilised benzoyl peroxide - Obagi Medical Products

Drug Profile

Solubilised benzoyl peroxide - Obagi Medical Products

Alternative Names: CLENZIderm M.D.; SoluCLENZ Rx Gel; SoluZyl Technology

Latest Information Update: 12 Nov 2016

Price : $50

At a glance

  • Originator Obagi Medical Products
  • Class Anti-infectives; Antiacnes; Benzoic acids; Oxidants; Peroxides; Small molecules
  • Mechanism of Action Keratinocyte inhibitors; Protein synthesis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

    No

Highest Development Phases

  • Marketed Acne vulgaris

Most Recent Events

  • 25 Apr 2013 Obagi Medical Products has been acquired by Valeant Pharmaceuticals International
  • 07 Mar 2009 Efficacy data from a clinical trial in Acne released by Obagi Medical Products
  • 11 Aug 2008 Launched into the Rx pharmacy-dispensing distribution channel for Acne vulgaris in USA (Topical, Gel)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top